Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens.

Sandbulte MR, Gao J, Straight TM, Eichelberger MC.

Influenza Other Respir Viruses. 2009 Sep;3(5):233-40.

2.

Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination.

van Maurik A, Sabarth N, Dacho HS, Brühl P, Schwendinger M, Crowe BA, Noel Barrett P, Kistner O, Keith Howard M.

Vaccine. 2010 Feb 17;28(7):1778-85. doi: 10.1016/j.vaccine.2009.12.008. Epub 2009 Dec 16.

PMID:
20018265
3.

Preexisting immunity to pandemic (H1N1) 2009.

Xing Z, Cardona CJ.

Emerg Infect Dis. 2009 Nov;15(11):1847-9. doi: 10.3201/eid1511.090685. No abstract available.

4.

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM.

N Engl J Med. 2009 Nov 12;361(20):1945-52. doi: 10.1056/NEJMoa0906453. Epub 2009 Sep 10.

5.

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses.

Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, Okamatsu M, Takahashi K, Warshauer D, Shult PA, Saito R, Suzuki H, Furuta Y, Yamashita M, Mitamura K, Nakano K, Nakamura M, Brockman-Schneider R, Mitamura H, Yamazaki M, Sugaya N, Suresh M, Ozawa M, Neumann G, Gern J, Kida H, Ogasawara K, Kawaoka Y.

Nature. 2009 Aug 20;460(7258):1021-5. doi: 10.1038/nature08260.

6.

Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team., Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM.

N Engl J Med. 2009 Jun 18;360(25):2605-15. doi: 10.1056/NEJMoa0903810. Epub 2009 May 7. Erratum in: N Engl J Med. 2009 Jul 2;361(1):102.

7.

Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge.

Jimenez GS, Planchon R, Wei Q, Rusalov D, Geall A, Enas J, Lalor P, Leamy V, Vahle R, Luke CJ, Rolland A, Kaslow DC, Smith LR.

Hum Vaccin. 2007 Sep-Oct;3(5):157-64. Epub 2007 Mar 20.

PMID:
17637571
8.

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ.

PLoS Med. 2007 Feb;4(2):e59.

9.

Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes.

Van Reeth K, Gregory V, Hay A, Pensaert M.

Vaccine. 2003 Mar 28;21(13-14):1375-81.

PMID:
12615433
10.

Eight-plasmid system for rapid generation of influenza virus vaccines.

Hoffmann E, Krauss S, Perez D, Webby R, Webster RG.

Vaccine. 2002 Aug 19;20(25-26):3165-70.

PMID:
12163268
11.

Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

Chen Z, Kadowaki S, Hagiwara Y, Yoshikawa T, Matsuo K, Kurata T, Tamura S.

Vaccine. 2000 Aug 1;18(28):3214-22.

PMID:
10869766
12.

Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice.

Johansson BE, Grajower B, Kilbourne ED.

Vaccine. 1993;11(10):1037-9.

PMID:
8212824
13.

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

Murphy BR, Kasel JA, Chanock RM.

N Engl J Med. 1972 Jun 22;286(25):1329-32. No abstract available.

PMID:
5027388
14.

Lack of association between titers of HAI antibody and whole-virus ELISA values for patients with congenital rubella syndrome.

Hancock EJ, Pot K, Puterman ML, Tingle AJ.

J Infect Dis. 1986 Dec;154(6):1031-3. No abstract available.

PMID:
3782867
15.

Supplemental Content

Support Center